Pandey Sandeep Kumar, Ahuja Vineet, Joshi Y K, Sharma M P
Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi 110 029.
Indian J Gastroenterol. 2004 Mar-Apr;23(2):53-5.
Relapse of pain during refeeding in acute pancreatitis may have a relation to the route of refeeding.
To compare the efficacy of oral refeeding with jejunal tube refeeding in patients with acute pancreatitis, and determine the frequency of refeeding pain and factors associated with it.
Consecutive patients with acute pancreatitis, severe enough to stop oral feeding for 48 hours, were randomized to receive either oral or jejunal tube refeeding. The feeds were similar in calorie, lipid and protein content (400 Kcal on day 1, 1000 Kcal on day 2, 1400 Kcal on day 3, 1500 Kcal on day 4, and 1700 Kcal on day 5). Clinical and biological factors (serum amylase, lipase, C-reactive protein) and Balthazar CT severity index were recorded. Frequency of pain relapse and factors associated with it were analyzed.
28 patients with acute pancreatitis (biliary 14, alcohol 9, idiopathic 3, post-ERCP 2) were included. Fifteen patients received oral and 13 received enteral tube refeeding. Four patients in the oral group and none in the enteral tube group had relapse of pain (p=0.06). The factors associated with refeeding pain were longer duration of initial pain (p<0.02) and higher CT severity index (p<0.02). Pain relapse increased the total hospital stay (p<0.004) and hospital stay after the first attempt at feeding (p<0.001).
Jejunal tube refeeding may reduce the frequency of pain relapse as compared to oral refeeding although the difference was not significant in this study. Longer duration of pain and higher CT severity index score were associated with occurrence of refeeding pain.
急性胰腺炎患者在重新进食期间疼痛复发可能与重新进食的途径有关。
比较急性胰腺炎患者口服重新进食与空肠管重新进食的效果,并确定重新进食疼痛的发生率及其相关因素。
连续入选因病情严重需停止口服进食48小时的急性胰腺炎患者,随机分为口服重新进食组或空肠管重新进食组。两组给予的食物在热量、脂肪和蛋白质含量方面相似(第1天400千卡,第2天1000千卡,第3天1400千卡,第4天1500千卡,第5天1700千卡)。记录临床和生物学因素(血清淀粉酶、脂肪酶、C反应蛋白)以及巴尔萨泽CT严重程度指数。分析疼痛复发的发生率及其相关因素。
纳入28例急性胰腺炎患者(胆源性14例,酒精性9例,特发性3例,内镜逆行胰胆管造影术后2例)。15例患者接受口服重新进食,13例接受肠内管饲重新进食。口服组有4例患者疼痛复发,肠内管饲组无患者疼痛复发(p = 0.06)。与重新进食疼痛相关的因素为初始疼痛持续时间较长(p < 0.02)和CT严重程度指数较高(p < 0.02)。疼痛复发增加了总住院时间(p < 0.004)以及首次尝试进食后的住院时间(p < 0.001)。
与口服重新进食相比,空肠管重新进食可能会降低疼痛复发的频率,尽管在本研究中差异不显著。疼痛持续时间较长和CT严重程度指数评分较高与重新进食疼痛的发生有关。